9 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Overview of Treatment Agents ... for COVID-19 - ... 2020 #Drugs #Medications ... #Treatment #COVID19 ... #Pharmacology #
COVID-19 Antiviral and Pharmacotherapy Recommendations

#COVID19 #Antiviral #Pharmacotherapy #Medications #Pharmacology #Management
COVID-19 Antiviral ... and Pharmacotherapy ... Recommendations #COVID19 ... #Antiviral #Pharmacotherapy ... #Medications #Pharmacology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
anti-hyperglycemic agents ... anti-hyperglycemic agents ... Each class of medications ... #pharmacology #pharmacotherapy ... comparison #management #medications
Neuropathic Pain: Pharmacotherapy Selection and Effectivity Decision Aid

Figure 2 provides a comparison icon array with natural
Neuropathic Pain: Pharmacotherapy ... Adverse events, ... contribute to medication ... #EBM #Pharmacology ... Effectiveness #Medications
COVID-19 Therapeutic Options Under Investigation

Carlos Saldana M.D. @CarlosSaldanaMD

#COVID19 #Antiviral #Pharmacotherapy #Medications #Pharmacology #Management
COVID-19 Therapeutic ... CarlosSaldanaMD #COVID19 ... #Antiviral #Pharmacotherapy ... #Medications #Pharmacology
Hydroxychloroquine and Chloroquine in COVID19

Dosing:
Hydroxychloroquine:
 - 400mg PO BID on the first day, followed by 200mg
Chloroquine in COVID19 ... - Second line agent ... #Chloroquine #COVID19 ... #HCQ #Pharmacology ... #Management #Medications
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Anti-IL6 Agents ... Siltuximab) in COVID19 ... correlate with severe COVID ... #Pharmacology # ... Management #Medications
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
Hepatitis C The new agents ... recommendations change frequently ... ambcarerx #HCV #Medications ... Classes #DAAs #Pharmacology
Pharmaceutical agents other than olmesartan have been reported to cause villous atrophy on occasion and are
Pharmaceutical agents ... to be the most frequent ... several other agents ... #Pharmacology #Drugs ... #Induced #Medications